Psychiatry and Neurology, Neurology · Raleigh, NC
NPI
1437268265
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
5
Medicare group memberships
Hospitals
3
Hospital affiliations
1540 Sunday Dr
Raleigh, NC, 27607
Phone (919) 782-3456
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.4M
72,462 services
Medicare patients, 2024
499
Average age 70
Drug cost, 2024
$8.1M
5,417 prescriptions
Company payments, 2025
$56K
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John R Scagnelli was code J2323 (injection, natalizumab, 1 mg), 18,900 times for 20 patients. In total John R Scagnelli billed 72,462 services in 58 codes, and Medicare paid $1.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-04-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2323 Injection, natalizumab, 1 mg | Office | 18,900 | 20 | $15.45 | $292K |
| J2350 Injection, ocrelizumab, 1 mg | Office | 12,000 | 17 | $26.30 | $316K |
| A9585 Injection, gadobutrol, 0.1 ml | Office | 5,496 | 66 | $0.24 | $1,297 |
| J2919 Injection, methylprednisolone sodium succinate, 5 mg | Office | 5,023 | 24 | $0.17 | $871 |
| J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 4,400 | 15 | $38.65 | $170K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 482 | 338 | $11.34 | $5,467 |
| 99215 Office E&M - Established | Office | 203 | 137 | $115.84 | $24K |
| 99214 Office E&M - Established | Office | 149 | 113 | $78.36 | $12K |
| 99204 Office E&M - New | Office | 142 | 142 | $103.22 | $15K |
| 96365 Intravenous Infusion, Hydration | Office | 134 | 44 | $41.73 | $5,591 |
| 96413 Chemotherapy Administration | Office | 67 | 35 | $85.60 | $5,735 |
| 99213 Office E&M - Established | Office | 65 | 59 | $57.35 | $3,728 |
| 70553 MRI/MRA - Head and Neck | Office | 65 | 64 | $117.61 | $7,645 |
| 96366 Intravenous Infusion, Hydration | Office | 56 | 16 | $14.23 | $797 |
| 70551 MRI/MRA - Head and Neck | Office | 34 | 31 | $86.99 | $2,958 |
By year: 2022 $644K for 37,840 services; 2023 $1.1M for 61,073 services; 2024 $1.4M for 72,462 services.
Medicare prescription drug claims, 2024
In 2024, the drug John R Scagnelli prescribed most often to Medicare patients was Gabapentin, with 417 prescriptions and refills. In total John R Scagnelli wrote 5,417 Medicare prescriptions that cost $8.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 417 | 601 | 92 | $7,657 |
| Donepezil Hcl Generic | 304 | 547 | 87 | $2,259 |
| Baclofen Generic | 268 | 508 | 70 | $7,598 |
| Pregabalin Generic | 179 | 210 | 38 | $4,388 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 172 | 271 | 49 | $2,496 |
| Tizanidine Hcl Generic | 147 | 249 | 47 | $2,939 |
| Dalfampridine Er Dalfampridine | 139 | 167 | 24 | $57K |
| Clonazepam Generic | 107 | 139 | 26 | $1,079 |
| Topiramate Generic | 107 | 202 | 24 | $894 |
| Kesimpta Pen Ofatumumab | 101 | 109 | 17 | $1.1M |
| Oxcarbazepine Generic | 96 | 187 | 29 | $5,193 |
| Duloxetine Hcl Generic | 87 | 204 | 25 | $2,043 |
| Lamotrigine Generic | 85 | 119 | 13 | $777 |
| Memantine Hcl Generic | 85 | 137 | 23 | $1,165 |
| Diazepam Generic | 81 | 97 | 31 | $500 |
Brand drugs: - claims; generic drugs: 4,598 claims; opioid claims: 188.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John R Scagnelli $56K ($56K in general payments such as food, travel and fees) from 31 companies. The largest payer was TG Therapeutics, Inc. with $32K.
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. TGTX | 83 | $32K |
| Amgen Inc. AMGN | 26 | $9,279 |
| Biogen, Inc. BIIB | 10 | $7,325 |
| Genentech USA, Inc. ROG.SW | 11 | $2,715 |
| Abbvie Inc. ABBV | 32 | $608 |
| Alexion Pharmaceuticals, Inc. AZN | 21 | $594 |
| Novartis Pharmaceuticals Corporation NVS | 30 | $567 |
| EMD Serono, Inc. MRK.DE | 19 | $522 |
| Celgene Corporation BMY | 48 | $368 |
| UCB, Inc. UCB.BR | 12 | $325 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.